Lilly

Short answer Which works better: clinical trials and head‑to‑head/indirect comparisons show tirzepatide (brand Zepbound) generally produces larger average weight loss than semaglutide (brand Wegovy). Which is easier to get online: neither is available without a prescription. Wegovy has been on the market longer and historically was somewhat easier to find through telehealth, but since Zepbound’s approval many reputable telehealth companies now evaluate and prescribe either drug. Availability will depend on the telehealth provider, your medical history, and your insurer. What the drugs are and how they compare Zepbound (tirzepatide) — a dual GIP + GLP‑1 receptor agonist. In obesity trials it produced larger mean weight losses than semaglutide in the published studies (trial data showed substantially greater average percent weight loss with tirzepatide doses vs semaglutide 2.4 mg in comparable trials). Wegovy (semaglutide) — a GLP‑1 receptor agonist and the established weight‑loss product used widely since its approval. It produces large, clinically meaningful weight loss but, on average in trials, less than tirzepatide. Side effects — both commonly cause gastrointestinal effects (nausea, diarrhea, constipation, vomiting). Tirzepatide may have similar or somewhat higher GI side‑effect rates in some studies. Long‑term comparative safety and cardiovascular outcome data are still being gathered for tirzepatide; semaglutide has a longer safety record. Practical differences Dosing/administration: both are once‑weekly injections. Insurance & cost: coverage varies. Many insurers were slow to cover weight‑loss drugs; both manufacturers run patient‑support and savings programs. Out‑of‑pocket cost can be high without coverage. Monitoring: both require medical evaluation before and during treatment (blood sugars, thyroid history, pancreatitis risk, pregnancy status, etc.). Getting them online — recommended, reputable options You cannot legally buy these without a prescription. If you want to pursue treatment online, consider these reputable telehealth options (they will evaluate you, order labs if needed, and — if appropriate — prescribe or refer to a specialty pharmacy): PlushCare — telemedicine primary‑care/weight‑management visits, broad network of physicians. Ro (Roman, Ro.com) — offers weight‑loss programs and prescriber evaluation; has been prescribing GLP‑1 therapies. Hims & Hers — telehealth platform that has weight‑loss/GLP‑1 programs. One Medical — membership primary‑care with virtual visits and chronic care management. Local endocrinologists/obesity clinics with telehealth — often best for complex medical history. Why these: they are established telemedicine providers that partner with licensed prescribers and legitimate pharmacies/specialty pharmacies rather than unregulated online stores. Safety warning — avoid unregulated sources Do not buy semaglutide/ tirzepatide from international online pharmacies that do not require a prescription or from online marketplaces that sell “cheap” injections. Risk of counterfeit, wrong dosing, improper storage, or contamination is real. Actionable next steps Talk to your primary care doctor or an obesity specialist to discuss medical eligibility and which drug fits your goals/medical history. If you prefer online, book with a reputable telehealth service above and be prepared to share medical history and recent labs. Check your insurer’s pharmacy policy and manufacturer savings programs (Novo Nordisk for Wegovy; Lilly for Zepbound) before starting. If you have diabetes, pregnancy plans, pancreatitis, personal/family medullary thyroid cancer or MEN syndromes, mention these to your clinician — they affect drug choice/safety. If you want, tell me: your main goal (how much weight you want to lose), any major health conditions or meds, and whether you prefer in‑person or telehealth — I can suggest the best next step and which telehealth provider is most likely to support the drug you prefer.

Mentioned in position 6 of 6